Ilmiya Yarullina, MD is affiliated with Supernus Pharmaceuticals, Inc., Rockville, Maryland. Ilmiya Yarullina has contributed 1 peer-reviewed article published across the Journal of Clinical Psychiatry and the Primary Care Companion for CNS Disorders in 2026. Their work focuses on Anxiety, Attention-Deficit/Hyperactivity Disorder, and Depression (MDD).
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
